Prostaglandin synthetase inhibitors as immunoadjuvants in the treatment of cancer.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D016861:Cyclooxygenase Inhibitors; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008264:Macrophages / Q000378:metabolism; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D011453:Prostaglandins / Q000096:biosynthesis
D000276:Adjuvants, Immunologic; D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins